MXPA03010996A - Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia. - Google Patents
Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia.Info
- Publication number
- MXPA03010996A MXPA03010996A MXPA03010996A MXPA03010996A MXPA03010996A MX PA03010996 A MXPA03010996 A MX PA03010996A MX PA03010996 A MXPA03010996 A MX PA03010996A MX PA03010996 A MXPA03010996 A MX PA03010996A MX PA03010996 A MXPA03010996 A MX PA03010996A
- Authority
- MX
- Mexico
- Prior art keywords
- therapy
- nicotinic acetylcholine
- acetylcholine receptors
- novel ligand
- receptors useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Abstract
Se describe un compuesto que tiene la formula (I); y cualesquiera sales farmaceuticamente aceptables del mismo, y sus usos en terapia y las composiciones que lo contienen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29520601P | 2001-06-01 | 2001-06-01 | |
PCT/SE2002/001031 WO2002096912A1 (en) | 2001-06-01 | 2002-05-29 | Novel ligand for nicotinic acetylcholine receptors useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03010996A true MXPA03010996A (es) | 2004-02-27 |
Family
ID=23136711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03010996A MXPA03010996A (es) | 2001-06-01 | 2002-05-29 | Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1397366B1 (es) |
JP (1) | JP2004532877A (es) |
KR (1) | KR20040003021A (es) |
CN (1) | CN1294136C (es) |
AT (1) | ATE353332T1 (es) |
BR (1) | BR0210075A (es) |
CA (1) | CA2455341A1 (es) |
DE (1) | DE60218032T2 (es) |
DK (1) | DK1397366T3 (es) |
ES (1) | ES2280538T3 (es) |
HK (1) | HK1063787A1 (es) |
IL (1) | IL158735A0 (es) |
MX (1) | MXPA03010996A (es) |
NO (1) | NO20035333D0 (es) |
NZ (1) | NZ529426A (es) |
PT (1) | PT1397366E (es) |
SI (1) | SI1397366T1 (es) |
WO (1) | WO2002096912A1 (es) |
ZA (1) | ZA200308779B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
NZ561993A (en) | 2002-04-18 | 2008-09-26 | Astrazeneca Ab | Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors |
EP1499618B1 (en) * | 2002-04-18 | 2010-10-13 | AstraZeneca AB | Furyl compounds |
US7186836B2 (en) * | 2002-04-18 | 2007-03-06 | Astrazeneca Ab | Thienyl compounds |
CN100494202C (zh) * | 2003-10-21 | 2009-06-03 | 阿斯利康(瑞典)有限公司 | 螺呋喃并吡啶芳基衍生物 |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
EA201001889A1 (ru) | 2008-06-20 | 2011-08-30 | Астразенека Аб | Производные дибензотиазепина и их применение |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
AU2011256287B2 (en) | 2010-05-17 | 2016-11-10 | Envivo Pharmaceuticals, Inc. | A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
US9593106B2 (en) | 2013-02-07 | 2017-03-14 | Heptares Therapeutics Limited | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists |
CA2914263C (en) | 2013-06-21 | 2021-05-18 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ500643A (en) * | 1997-05-30 | 2001-12-21 | Neurosearch As | Spiro-quinuclidine derivatives and their use in treating conditions responsive to nicotinic ACh receptor modulators |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
-
2002
- 2002-05-29 DK DK02731063T patent/DK1397366T3/da active
- 2002-05-29 NZ NZ529426A patent/NZ529426A/en unknown
- 2002-05-29 JP JP2003500091A patent/JP2004532877A/ja active Pending
- 2002-05-29 AT AT02731063T patent/ATE353332T1/de not_active IP Right Cessation
- 2002-05-29 SI SI200230510T patent/SI1397366T1/sl unknown
- 2002-05-29 EP EP02731063A patent/EP1397366B1/en not_active Expired - Lifetime
- 2002-05-29 CA CA002455341A patent/CA2455341A1/en not_active Abandoned
- 2002-05-29 WO PCT/SE2002/001031 patent/WO2002096912A1/en active IP Right Grant
- 2002-05-29 DE DE60218032T patent/DE60218032T2/de not_active Expired - Fee Related
- 2002-05-29 KR KR10-2003-7015462A patent/KR20040003021A/ko not_active Application Discontinuation
- 2002-05-29 BR BR0210075-4A patent/BR0210075A/pt not_active IP Right Cessation
- 2002-05-29 CN CNB028110498A patent/CN1294136C/zh not_active Expired - Fee Related
- 2002-05-29 PT PT02731063T patent/PT1397366E/pt unknown
- 2002-05-29 IL IL15873502A patent/IL158735A0/xx unknown
- 2002-05-29 MX MXPA03010996A patent/MXPA03010996A/es active IP Right Grant
- 2002-05-29 ES ES02731063T patent/ES2280538T3/es not_active Expired - Lifetime
-
2003
- 2003-11-11 ZA ZA200308779A patent/ZA200308779B/en unknown
- 2003-11-28 NO NO20035333A patent/NO20035333D0/no unknown
-
2004
- 2004-09-01 HK HK04106588A patent/HK1063787A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1397366B1 (en) | 2007-02-07 |
ZA200308779B (en) | 2005-02-11 |
ES2280538T3 (es) | 2007-09-16 |
NO20035333D0 (no) | 2003-11-28 |
DK1397366T3 (da) | 2007-05-07 |
HK1063787A1 (en) | 2005-01-14 |
CN1294136C (zh) | 2007-01-10 |
IL158735A0 (en) | 2004-05-12 |
BR0210075A (pt) | 2004-08-17 |
WO2002096912A1 (en) | 2002-12-05 |
CA2455341A1 (en) | 2002-12-05 |
DE60218032D1 (de) | 2007-03-22 |
ATE353332T1 (de) | 2007-02-15 |
SI1397366T1 (sl) | 2007-06-30 |
CN1512995A (zh) | 2004-07-14 |
EP1397366A1 (en) | 2004-03-17 |
KR20040003021A (ko) | 2004-01-07 |
PT1397366E (pt) | 2007-04-30 |
DE60218032T2 (de) | 2007-08-16 |
NZ529426A (en) | 2005-07-29 |
JP2004532877A (ja) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL158735A0 (en) | Novel ligand for nicotinic acetylcholine receptors useful in therapy | |
MXPA03006093A (es) | Derivados de n(fenilsulfonil)glicina y su uso terapeutico. | |
CY1113054T1 (el) | Παραγωγα διαμινης | |
DE60112974D1 (en) | Carbolinderivate | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
HK1080470A1 (en) | Heterocyclic compounds | |
ATE417049T1 (de) | Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten | |
MXPA02011977A (es) | Herbicidas de piridina sustituidas. | |
HK1079522A1 (en) | Thienyl compounds | |
GEP20105081B (en) | Pyrrolotriazine compounds as kinase inhibitors | |
UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
DE60216233D1 (en) | Carbolinderivate | |
MX2007006743A (es) | Ligandos del receptor de acetilcolina nicotinica. | |
TNSN05133A1 (en) | Imidazoquinoline derivatives as adenosine a3 receptor ligands | |
YU39803A (sh) | Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora | |
MXPA02012076A (es) | Compuestos quimicos. | |
TW200519111A (en) | N3-substituted imidazopyridine C-KIT inhibitors | |
AU2001266575A1 (en) | Chemical compounds | |
DE60315826D1 (de) | Neue verbindungen | |
TW200508199A (en) | Novel compound | |
GB0018951D0 (en) | Novel compounds | |
TR200402546T4 (tr) | Taksan türevleri hazırlamak için işlem. | |
UA87813C2 (ru) | Система контролируемого высвобождения темозоломида | |
MXPA02012472A (es) | Compuestos quimicos. | |
GB0027705D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |